We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer.
- Authors
Paz-Ares, Luis G; Biesma, Bonne; Heigener, David; von Pawel, Joachim; Eisen, Timothy; Bennouna, Jaafar; Zhang, Li; Liao, Meilin; Sun, Yan; Gans, Steven; Syrigos, Kostas; Le Marie, Etienne; Gottfried, Maya; Vansteenkiste, Johan; Alberola, Vincente; Strauss, Uwe Phillip; Montegriffo, Elaine; Ong, Teng Jin; Santoro, Armando; NSCLC non–small-cell lung cancer] Research Experience Utilizing Sorafenib (NExUS) Investigators Study Group
- Abstract
This trial evaluated the efficacy and safety of sorafenib plus gemcitabine/cisplatin in chemotherapy-naive patients with unresectable stage IIIB to IV nonsquamous non-small-cell lung cancer (NSCLC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Vol 30, Issue 25, p3084
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2011.39.7646